CGS-CIMB Research

Broker's Calls

CGS-CIMB raises EPS estimates as StarHub’s 1HFY2023 surpasses expectations

The brokerage retained its ‘hold’ call as StarHub may take time to reap fruits of its transformative efforts: CGS-CIMB

Broker's Calls

Higher rental reversions and occupancies in Singapore keep analysts upbeat on Starhill Global REIT

Although the REIT recorded a lower DPU and earnings for the 2HYF2022/2023, DBS and CGS-CIMB have kept their “buy” and “add” calls.

Broker's Calls

Analysts mixed on CICT’s DPU outlook as interest costs expected to increase in 2HFY2023

Analysts from CGS-CIMB and DBS have kept their "buy" and "add" calls, while RHB has stayed "neutral".
Double whammy from interest and utilities, CGS-CIMB keeps 'hold' on MPACT with lower TP of $1.76 - THE EDGE SINGAPORE

Broker's Calls

Double whammy from interest and utilities, CGS-CIMB keeps 'hold' on MPACT with lower TP of $1.76

The analysts expect Festival Walk's negative reversion trend to continue for FY2024.

Broker's Calls

Analysts cheer Keppel Corp’s ‘solid’ 1HFY2023 results and KREIT distribution

The analysts' target prices range from $8.30 to $9.09.

Broker's Calls

CGS-CIMB maintains 'hold' on OUE C-REIT and TP of 36 cents citing lack of near-term catalysts

The REIT’s DPU of 1.05 cents for 1HFY2023, down 2.8% y-o-y, was in line with 49.5% of the brokerage's full-year forecast.
'Scant near-term re-rating catalysts' for Hongkong Land, CGS-CIMB reiterates 'hold' - THE EDGE SINGAPORE

Broker's Calls

'Scant near-term re-rating catalysts' for Hongkong Land, CGS-CIMB reiterates 'hold'

CGS-CIMB has reiterated their “hold” with an unchanged TP of US$4.
Raffles Medical's 1HFY2023 results likely to have set a new baseline of profitability, analysts keep 'buy' - THE EDGE SINGAPORE

Broker's Calls

Raffles Medical's 1HFY2023 results likely to have set a new baseline of profitability, analysts keep 'buy'

Raffles Medical is Maybank’s preferred pick in the healthcare sector.

Broker's Calls

Analysts overall positive on UOB after ‘decent’ 2QFY2023 results

Analysts have mostly kept their "add" or "buy" calls except DBS, which has kept its "hold" call.
 Analysts mostly positive on Seatrium despite $264 mil loss in 1HFY2023 - THE EDGE SINGAPORE

Broker's Calls

Analysts mostly positive on Seatrium despite $264 mil loss in 1HFY2023

CGS-CIMB, OCBC and DBS have maintained their “add” and “buy” calls, while Citi is keeping “sell” on Seatrium.
×